Overview

Bioequivalence Study of Clopid® (Clopidogrel) 75 mg Tablet and Plavix® 75 mg Tablet After Oral Administration to Healthy Adult Subjects Under Fasting Condition

Status:
Completed
Trial end date:
2018-04-20
Target enrollment:
Participant gender:
Summary
To compare the rate and extent of absorption of Clopid® (Clopidogrel) 75 mg Tablet and Plavix® (clopidogrel) 75 mg tablet under fasting condition.
Phase:
Phase 1
Details
Lead Sponsor:
Center for Bioequivalence Studies and Clinical Research
Collaborator:
Ferozsons Laboratories Ltd.
Treatments:
Clopidogrel